Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_provenance.
- NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_assertion description "[Together, our findings suggest that selectively targeting tumor-elicited myeloid cells or versican represents a potential therapeutic strategy for combating metastatic disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_provenance.
- NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_assertion evidence source_evidence_literature NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_provenance.
- NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_assertion SIO_000772 22282653 NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_provenance.
- NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_assertion wasDerivedFrom befree-2016 NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_provenance.
- NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_assertion wasGeneratedBy ECO_0000203 NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_provenance.
- befree-2016 importedOn "2016-02-19" NP956463.RALrI1o5YZoVG1_7h-nhXNdzbaRxMkMOIrIghg_q4oxKI130_provenance.